SEC Form D · Amendment · filed September 12, 2025
Psy Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Jeff S. Troderman · Boston, MAExecJerry F. Rosenbaum · Boston, MADirectorAlan S. Cross · Boston, MADirectorPaul F. Murphy · Boston, MADirectorDavid S. Barlow · Boston, MAExec · DirectorDaniel S. Weiss Pick · Boston, MADirectorWilliam F. Wagner · Boston, MAExecChristopher G. Carter · DALLAS, TXDirectorPaul F. Murphy · Boston, MADirectorPhillip Mertz · Vancouver, British Columbia, CanadaExecCastle Ridge Ltd · Grand Cayman, Cayman IslandsDirectorAdrian De Valois-Franklin · Toronto, Ontario, CanadaDirectorGiada De Laurentiis · Los Angeles, CAExecB.P. Martiuk · Grand Cayman, Cayman IslandsExec · DirectorKarl O'Reilly · Grand Cayman, Cayman IslandsExec · DirectorMarc V. Teillon · SAN FRANCISCO, CADirectorStephen A. Foster · SAN FRANCISCO, CADirectorKyle A. Kuczynski · Reno, NVDirectorWilliam P. Vernon · Reno, NVExecJason D. Molt · Reno, NVExecCurtis A. Lockshin, Ph.D · Marlborough, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗